DSIP
A peptide named for early sleep research, with a small and dated body of published literature.
Also known as: Delta sleep-inducing peptide
At a Glance
A peptide named for early sleep research, with a small and dated body of published literature.
Common Areas of Interest
Commonly discussed or studied in relation to:
Why People Are Interested
Its name and early research history make it a recurring topic in online sleep and wellness discussions.
Evidence Snapshot
Research is sparse, largely historic, and not sufficient to characterise real-world use.
Human research: Very limited human data.
Regulatory / Research Status
Not an approved treatment for sleep or any other use.
Approval for one specific indication never implies approval or suitability for wellness, cosmetic, or anti-aging uses.
What We Know
- It was identified in early sleep-physiology research.
- Modern, high-quality human research is largely absent.
What We Don't Know Yet
- Effectiveness for sleep quality in people.
- Safety profile with ongoing use.
Important Considerations
- Sleep difficulties have many causes worth discussing with a clinician.
- A memorable name is not evidence.
Questions to Ask Your Healthcare Provider
- What evidence supports this peptide for the goal I'm interested in?
- Is this peptide approved for this particular use?
- What benefits are supported by human evidence?
- What risks or side effects should I understand?
- What important unknowns remain?
Sources
- Overview literature relating to DSIP
Placeholder — reputable reference to be added · Pending review
- Regulatory status information
Placeholder — official regulatory source to be added · Pending review
Last reviewed: 2026-08-01